feed,title,long_url,short_url
Benzinga,"Despite Failed Phase 3 Study, FDA Staff Says Biogen's ALS Drug May Have Clinical Benefit",https://benzinga.com/general/biotech/23/03/31433167/despite-failed-phase-3-study-fda-staff-says-biogens-als-drug-may-have-clinical-benefit,https://da.gd/T5KWhU
